Schedule 13D ownership disclosure
SYNTA PHARMACEUTICALS CORP
Security class unavailable · CUSIP: 87162T206
Event date: 2015-03-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-15-003505
- Form type
- SC 13D
- Filer
- CxSynta LLC
- CIK
- CIK 1388171
- Filed
- Apr 10, 2015
- Reporting period
- Mar 31, 2015
- Description
- Schedule 13D beneficial ownership